Literature DB >> 23768558

Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?

A Vrieze1, P F de Groot, R S Kootte, M Knaapen, E van Nood, M Nieuwdorp.   

Abstract

Recent studies have suggested an association between intestinal microbiota composition and human disease, however causality remains to be proven. With hindsight, the application of fecal transplantation (FMT) does indeed suggest a causal relation between interfering with gut microbiota composition and a resultant cure of several disease states. In this review, we aim to show the available evidence regarding the involvement of intestinal microbiota and human (autoimmune) disease. Moreover, we refer to (mostly case report) studies showing beneficial or adverse effects of fecal transplantation on clinical outcomes in some of these disease states. If these findings can be substantiated in larger randomized controlled double blind trials also implementing gut microbiota composition before and after intervention, fecal transplantation might provide us with novel insights into causally related intestinal microbiota, that might be serve as future diagnostic and treatment targets in human disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23768558     DOI: 10.1016/j.bpg.2013.03.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  27 in total

1.  Emergence of collective territorial defense in bacterial communities: horizontal gene transfer can stabilize microbiomes.

Authors:  János Juhász; Attila Kertész-Farkas; Dóra Szabó; Sándor Pongor
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

Review 2.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

3.  Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.

Authors:  Shinta Mizuno; Tatsuhiro Masaoka; Makoto Naganuma; Taishiro Kishimoto; Momoko Kitazawa; Shunya Kurokawa; Moeko Nakashima; Kozue Takeshita; Wataru Suda; Masaru Mimura; Masahira Hattori; Takanori Kanai
Journal:  Digestion       Date:  2017-06-21       Impact factor: 3.216

4.  Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing.

Authors:  Ravi Ranjan; Asha Rani; Ahmed Metwally; Halvor S McGee; David L Perkins
Journal:  Biochem Biophys Res Commun       Date:  2015-12-22       Impact factor: 3.575

5.  Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.

Authors:  Susana Fuentes; Els van Nood; Sebastian Tims; Ineke Heikamp-de Jong; Cajo J F ter Braak; Josbert J Keller; Erwin G Zoetendal; Willem M de Vos
Journal:  ISME J       Date:  2014-02-27       Impact factor: 10.302

Review 6.  Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.

Authors:  Noortje G Rossen; John K MacDonald; Elisabeth M de Vries; Geert R D'Haens; Willem M de Vos; Erwin G Zoetendal; Cyriel Y Ponsioen
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 7.  Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD.

Authors:  Manisha Gupta; Pawan Krishan; Amarjot Kaur; Sandeep Arora; Nirupma Trehanpati; Thakur Gurjeet Singh; Onkar Bedi
Journal:  Inflamm Res       Date:  2021-07-01       Impact factor: 4.575

8.  Approaches to studying and manipulating the enteric microbiome to improve autism symptoms.

Authors:  Richard E Frye; John Slattery; Derrick F MacFabe; Emma Allen-Vercoe; William Parker; John Rodakis; James B Adams; Rosa Krajmalnik-Brown; Ellen Bolte; Stephen Kahler; Jana Jennings; Jill James; Carl E Cerniglia; Tore Midtvedt
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

Review 9.  Prospects for therapeutic tolerance in humans.

Authors:  Kenneth F Baker; John D Isaacs
Journal:  Curr Opin Rheumatol       Date:  2014-03       Impact factor: 5.006

10.  Pawnobiome: manipulation of the hologenome within one host generation and beyond.

Authors:  Jameson D Voss; Juan C Leon; Nikhil V Dhurandhar; Frank T Robb
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.